CMB International Raises INNOSCIENCE Target Price to HK$75, Keeps Buy Rating

Stock News
04/02

CMB International has released a research report significantly raising the target price for INNOSCIENCE (02577) by 53.1% from HK$49 to HK$75, while maintaining a "Buy" rating. The report highlights the company's fiscal year 2025 results, which showed revenue increasing by 46.4% year-over-year to RMB 1.2 billion, with gross margin turning positive to 7.3%. Adjusted EBITDA also turned positive, marking the company's first significant operational inflection point. The improvement in profitability was primarily driven by ongoing capacity expansion, with monthly wafer capacity reaching 20,000 units by 2025, alongside simultaneous improvements in capacity utilization and yield rates. Beyond financial performance, fiscal year 2025 was also a crucial year for the company's commercial progress, including: 1) deeper collaboration with leading AI clients such as NVIDIA and Google on 800V DC power architecture; 2) initial expansion into the humanoid robotics sector through a 100V integrated GaN driver for joint modules; and 3) solid advancements in the automotive business, progressing from volume shipments of OBC/DC-DC converters to the initial verification stage for main drive inverters.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10